Hirshberg Foundation for Pancreatic Cancer Research

Dedicated to advancing pancreatic cancer research and providing support to patients and their families.

Donate
  • ABOUT THE FOUNDATION
    • Agi’s Story
    • About Us →
      • Mission
      • Directors/Trustees
      • Scientific Advisory Board
      • How Our Journey Began
    • News →
      • Latest News
      • Research News
      • Foundation News
      • UCLA Activity Summary Reports
      • Newsletters
      • Press Room
    • Contact
  • PANCREATIC CANCER
    • About the Pancreas →
      • The Pancreas
      • Cancer Cells
      • Risk Factors
      • Symptoms
      • Diagnosis
      • Prognosis
      • Staging
      • Second Opinion
    • Treatment Options →
      • Surgery
      • Chemotherapy
      • Targeted Therapy
      • Radiation Therapy
      • Alternative Treatment Options
      • Clinical Trials
    • Supportive Care →
      • Obstructions
      • Pain Control
      • Nutrition
      • Cannabis
      • Palliative Care
    • Pancreatic Cancer Facts
    • Glossary of Terms
    • Frequently Asked Questions
  • RESEARCH
    • Seed Grant Program →
      • Seed Grant Recipients
      • Frequently Asked Questions
    • Seed Grant News
    • UCLA Program →
      • UCLA Center for Pancreatic Diseases
      • Basic Research
      • Translational Research
      • Sahin-Toth Laboratory
      • UCLA Pancreas Tissue Bank
      • UC Pancreatic Cancer Consortium
      • Simms/Mann Psychosocial →
        • Insights into Cancer
    • American Pancreatic Association
    • NIH Funded Projects
  • PATIENTS & CAREGIVERS
    • Patient Support
    • Where to Begin
    • Caregivers & Families
    • Symposium →
      • Symposium Presentations
    • Patient & Family Webinars
    • Genetic Counseling
    • Resources →
      • NCCN Guidelines for Patients
      • Patient Support Tools
      • Create Your Health Care Team
      • Patient Health Diaries
      • Support Groups
      • Financial Aid
  • HOW YOU CAN HELP
    • Planned Giving
    • Donor-Advised Funds
    • Event Calendar
    • Get Inspired
    • Fundraising Resources
    • November Awareness Month →
      • World Pancreatic Cancer Day
    • More Ways to Give →
      • You Can Help Funds
      • Host Your Own Event
      • Shop Online Store
      • Wedding Program
      • Volunteer
      • Car Program
  • SEARCH
Home / Research / Seed Grant Program / Seed Grant Recipients / Jimin Min, PhD

Jimin Min, PhD

Jimin Min, PhD
Jimin Min, PhD
UT MD Anderson Cancer Center

Spatial omics profiling to assess the impact of aging on the normal and neoplastic pancreas

Overview

Aim: Cancer Biology

Pancreatic cancer is the 3rd most common cause of cancer-related deaths in the United States. While the median age of onset for pancreatic cancer is in the late 60s, there has been a striking and worrisome increase in the annual incidence of early-onset pancreatic cancer (EOPC), defined as cancer in individuals less than 50 years of age, with recent trends showing an 18% increase of EOPC in just the past decade. Previous studies have examined how DNA abnormalities (mutations) differ between EOPC and usual-onset pancreatic cancer (UOPC), but these at best explain only a minority of cases. Thus, the underlying bases for increasing EOPC incidence remain largely unknown.

We hypothesize that EOPC represents a disease of accelerated aging within the pancreatic “soil” that creates a fertile milieu for cancer development. Therefore, the first step to addressing the enigma of EOPC begins with creating a comprehensive molecular “atlas” that goes beyond the tumor itself, but also examines the proverbial “soil” (adjacent uninvolved pancreas).

We will integrate multiple analytes (DNA, RNA, and protein alterations) in an unbiased manner to create the first molecular atlas comparing EOPC versus UOPC, including changes within the surrounding pancreas. Notably, we will utilize a unique series of age-matched pancreas samples obtained from cancer-free organ donors as pivotal controls for how “normal aging” might differ from “accelerated aging” we anticipate in EOPC. This study will provide crucial foundational data for elucidating the mechanisms underlying EOPC.

Research

  • Seed Grant Program
    • Seed Grant Recipients
      • Katelyn T. Byrne, PhD
      • Julienne L. Carstens, PhD
      • Alicia K. Fleming Martinez, PhD
      • Mark Girgis, MD
      • Conan Kinsey, MD, PhD
      • Jacques Lux, PhD
      • Jimin Min, PhD
      • Somnath Pandey, PhD
      • Fredrik Ivar Thege, PhD
      • Liying Zhang, MD, PhD
  • Seed Grant News
  • UCLA Program
    • UCLA Center for Pancreatic Diseases
    • Basic Research
    • Translational Research
    • Sahin-Toth Laboratory
    • UCLA Pancreas Tissue Bank
    • UC Pancreatic Cancer Consortium
    • Psychosocial Care via Simms/Mann
      • Insights into Cancer
  • American Pancreatic Association (APA)
  • NIH Funded Projects

Patient Support Resources

from the comfort of your home


Our Webinar Library »

Never Give Up.
The journey continues with an end in sight.
Our Stories »
SUBSCRIBE
Our Free E-Newsletter
Sign up to receive information on breaking news, patient programs and upcoming events.
You can custom tailor your subscriptions and unsubscribe at any time.
  • How You Can Help
  • Make A Donation
  • Host an Event
  • Shop Online Store
  • Signature Events
  • L.A. Cancer Challenge
  • Tour De Pier
  • Hirshberg Training Team
  • More
  • News
  • Press
  • Contact

Stay Connected

Join Our E-newsletter

  • Legal and Privacy
  • Financial Information
  • Contact